Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphanie Blockhuys

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Biochemical and Biophysical Research Communications|December 29, 2016
Copper chaperone Atox1 plays role in breast cancer cell migrationStéphanie Blockhuys, Pernilla Wittung-Stafshede
International Journal of Molecular Sciences|April 21, 2017
Roles of Copper-Binding Proteins in Breast CancerStéphanie Blockhuys, Pernilla Wittung-Stafshede
Complementary Medicine Research|July 11, 2024
Yoga as a Complementary Therapy for Cancer Patients: From Clinical Observations to Biochemical MechanismsStéphanie Blockhuys, Pernilla Wittung-Stafshede
Biointerphases|December 23, 2018
Copper distribution in breast cancer cells detected by time-of-flight secondary ion mass spectrometry with delayed extraction methodologyStéphanie Blockhuys, Per Malmberg, Pernilla Wittung-Stafshede
Proceedings of the National Academy of Sciences of the United States of America|January 15, 2020
Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migrationStéphanie Blockhuys, Xiaolu Zhang, Pernilla Wittung-Stafshede
Breast Cancer (Tokyo, Japan)|January 4, 2020
Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancerStéphanie Blockhuys, Donita C Brady, Pernilla Wittung-Stafshede
Biomedicines|December 24, 2021
Evaluation of ATOX1 as a Potential Predictive Biomarker for Tetrathiomolybdate Treatment of Breast Cancer Patients with High Risk of RecurrenceStéphanie Blockhuys, Camilla Hildesjö, Hans Olsson, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|June 8, 2020
The Caenorhabditis elegans homolog of human copper chaperone Atox1, CUC-1, aids in distal tip cell migrationXiaolu Zhang, Stéphanie Blockhuys, Ranjan Devkota, et al.
Mutation Research|February 25, 2010
From clinical observations of intensity-modulated radiotherapy to dedicated in vitro designsStéphanie Blockhuys, Barbara Vanhoecke, Carlos De Wagter, et al.
Journal of Biomedical Optics|October 12, 2017
Second harmonic generation for collagen I characterization in rectal cancer patients with and without preoperative radiotherapyStéphanie Blockhuys, Nisha Rani Agarwal, Camilla Hildesjö, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|December 29, 2016
Copper chaperone Atox1 plays role in breast cancer cell migrationStéphanie Blockhuys, Pernilla Wittung-Stafshede
International Journal of Molecular Sciences|April 21, 2017
Roles of Copper-Binding Proteins in Breast CancerStéphanie Blockhuys, Pernilla Wittung-Stafshede
Complementary Medicine Research|July 11, 2024
Yoga as a Complementary Therapy for Cancer Patients: From Clinical Observations to Biochemical MechanismsStéphanie Blockhuys, Pernilla Wittung-Stafshede
Biointerphases|December 23, 2018
Copper distribution in breast cancer cells detected by time-of-flight secondary ion mass spectrometry with delayed extraction methodologyStéphanie Blockhuys, Per Malmberg, Pernilla Wittung-Stafshede
Proceedings of the National Academy of Sciences of the United States of America|January 15, 2020
Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migrationStéphanie Blockhuys, Xiaolu Zhang, Pernilla Wittung-Stafshede
Breast Cancer (Tokyo, Japan)|January 4, 2020
Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancerStéphanie Blockhuys, Donita C Brady, Pernilla Wittung-Stafshede
Biomedicines|December 24, 2021
Evaluation of ATOX1 as a Potential Predictive Biomarker for Tetrathiomolybdate Treatment of Breast Cancer Patients with High Risk of RecurrenceStéphanie Blockhuys, Camilla Hildesjö, Hans Olsson, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|June 8, 2020
The Caenorhabditis elegans homolog of human copper chaperone Atox1, CUC-1, aids in distal tip cell migrationXiaolu Zhang, Stéphanie Blockhuys, Ranjan Devkota, et al.
Mutation Research|February 25, 2010
From clinical observations of intensity-modulated radiotherapy to dedicated in vitro designsStéphanie Blockhuys, Barbara Vanhoecke, Carlos De Wagter, et al.
Journal of Biomedical Optics|October 12, 2017
Second harmonic generation for collagen I characterization in rectal cancer patients with and without preoperative radiotherapyStéphanie Blockhuys, Nisha Rani Agarwal, Camilla Hildesjö, et al.
Pageof 2